| ECAT | LCR | ECAT / LCR | |
| Gain YTD | 18.979 | 10.286 | 185% |
| Net Assets | 1.66B | 69.7M | 2,385% |
| Total Expense Ratio | 1.30 | 0.84 | 155% |
| Turnover | 227.00 | 50.36 | 451% |
| Yield | 1.62 | 1.68 | 96% |
| Fund Existence | 4 years | 6 years | - |
| ECAT | LCR | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 74% | 2 days ago 63% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 53% |
| MACD ODDS (%) | 2 days ago 75% | 2 days ago 59% |
| TrendWeek ODDS (%) | 2 days ago 87% | 2 days ago 80% |
| TrendMonth ODDS (%) | 2 days ago 87% | 2 days ago 64% |
| Advances ODDS (%) | 3 days ago 85% | 3 days ago 79% |
| Declines ODDS (%) | 29 days ago 79% | 11 days ago 58% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 76% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FEYTX | 31.01 | N/A | N/A |
| Fidelity Advisor Asset Manager 85% M | |||
| RRGIX | 7.39 | -0.06 | -0.81% |
| DWS RREEF Global Real Estate Secc Inst | |||
| UIVVX | 13.09 | -0.19 | -1.43% |
| MFS Intrinsic Value A | |||
| HIGUX | 22.38 | -0.37 | -1.63% |
| Carillon Eagle Growth & Income R6 | |||
| ETNHX | 45.05 | -0.90 | -1.96% |
| Eventide Healthcare & Life Sciences N | |||
A.I.dvisor indicates that over the last year, ECAT has been loosely correlated with BSX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ECAT jumps, then BSX could also see price increases.
| Ticker / NAME | Correlation To ECAT | 1D Price Change % | ||
|---|---|---|---|---|
| ECAT | 100% | -1.22% | ||
| BSX - ECAT | 64% Loosely correlated | +0.82% | ||
| CRM - ECAT | 62% Loosely correlated | -2.27% | ||
| AMT - ECAT | 56% Loosely correlated | -1.21% | ||
| NEE - ECAT | 55% Loosely correlated | -2.21% | ||
| MSFT - ECAT | 12% Poorly correlated | -1.54% | ||
More | ||||